My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Tesla Q3 EV Delivery Volumes Would Be In 440k...
Target Better Have My New Products: Rihanna,...
Declaring Victory On Inflation Would Be 'Prem...
Has Nike Stock Bottomed? Analysts Explore Q1...
Washington State Considers Fingerprint Scans...
Turo's IPO Reboot: Ride-Sharing Platform Aims...
Senator Dianne Feinstein Passes Away At 90 Am...
Starbucks Found Guilty For Manipulating Emplo...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    JOHNSON & JOHNSON (NYSE: JNJ)

    Overview
    current price
    $155.75
    $155.75
    change
    -1.13 | -0.72%
    -1.13 | -0.72%
    Yesterday's Close
    156.88
    open
    157.37
    volume
    7.68 M
    30d. avg volume.
    22.30 M
    1 day
    155.35 - 157.60
    52 weeks
    150.11 - 181.04
    p/e
    31.59
    beta
    0.5423
    market cap
    375.05 B
    dividend yield
    3.06%
    Industry
    -
    JNJ by TradingView
    News and Commentary
    Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs AstraZeneca Plc (AZN&nb...
    Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson, Procter & Gamble Face Allegations In a recent lawsuit, Johnson & Johnson (
    AI Integration In Biotech & Pharma: Companies Positioned To Benefit The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug dis...
    Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Inn... Johnson & Johnson (JNJ&...
    A Step Closer To Cheaper Drugs For Americans: Price Negotiation And Its Implications Some of the most frequently prescribed medications in the U.S. might soon become more affordable. This change could result in significant taxpayer savings but may challenge the p...
    Russia Is Seizing European Company Assets — What US Businesses Are Still At Risk? In recent months, Russia began seizing assets from companies based in Western countries.The most recent development came last week, when the Russian gov...
    Sales Of Johnson & Johnson Esketamine Drug Spravato Rise Nearly 100% Year Over Year Global pharmaceutical behemoth Johnson & Johnson (
    Market Update: Dow Climbs 150 Points Higher for Ninth Straight Positive Day The Dow Jones Industrial Average rose for a ninth consecutive day on Thursday as strong earnings continued to propel the index higher. However, the S&P 500 Index and Nasdaq Compo...
    Drug Pricing Negotiation Program: Johnson & Johnson Joins Legal Battle Against US Government Johnson & Johnson (JNJ&...
    Market Update: Dow Posts Best Week Since March Stocks were mixed Friday with the Dow Jones Industrial Average climbing 100 points as strong earnings from some big banks and companies lifted the index higher. Meanwhile, the S&...
    StockTwits
    StockTwits
    Most Shared
    Morgan Stanley Sees Mattel Rising Amidst Challenges, Boosted by Barbie Movie Success and IP Monetization Prospects
    Dimon Pours Cold Water On US Economic Optimism, Flags Global Tensions, Financial Shifts
    Meta's Stock Price Soars Past $300 - As The Tech Giant Sets New Ambitions, Investors Eye Unprecedented Record Highs
    Most Popular
    Dollar General Navigating Choppy Waters but Not Sinking Yet, Says Analyst
    Microsoft Could Be Launching AI-Powered Smart Backpacks: Here Are Some Use Cases
    Lululemon Continues Its Quarterly Report Winning Streak and Shows It Is Worthy of Challenging Nike
    popular tags
    Earnings
    Coronavirus
    Coronavirus Impact
    Covid-19
    Amazon
    Covid19
    Apple
    China
    Google
    mobile iOS Android
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2023 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?